Tokyo, Aug. 31 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062422) titled 'Follow-up interview study on perceptions of the impact of daily alcohol consumption and acceptability of digital support' on Aug. 31.
Study Type:
Observational
Primary Sponsor:
Institute - Macromill Carenet, Inc.
Condition:
Condition - Healthy subjects
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - This study will be conducted to examine perceptions of the effects of alcohol consumption on sleep, physical condition, work performance, and other aspects of daily life, as well as the acceptability of, trust in, and concerns about digital support technologies.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 20
years-old
Gender - Male and Female
Key inclusion criteria - 1. Persons who participated in the relevant prior study
2. Persons who have received a sufficient explanation regarding the purpose and contents of this study, have the capacity to give informed consent, can understand the details well, and give their own consent via electronic informed consent
Key exclusion criteria - 1. Persons who did not participate in the relevant prior study
Target Size - 20
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 07 Month 30 Day
Date of IRB - 2026 Year 07 Month 30 Day
Anticipated trial start date - 2026 Year 07 Month 31 Day
Last follow-up date - 2026 Year 08 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071444
Disclaimer: Curated by HT Syndication.
